by SEO Luxeveda | Mar 2, 2026 | Immunoenicity, Discovery Biology, Discovery Solutions, Insights, Blogs
As the immuno-oncology landscape continues to expand, the demand for robust, reproducible, and mechanistically informative in vitro assay systems has grown in parallel. Mixed Lymphocyte Reaction assays have emerged as one of the most relevant tools for evaluating the...
by abishek | Oct 24, 2025 | Insights, Immunoenicity, Brochures
Introduction De-risk your synthetic peptide drug products with PI Health Sciences’ comprehensive immunogenicity risk assessment platform. We use advanced in vitro immunogenicity assays with human primary cells to evaluate both innate and adaptive immune responses,...
